Oncotech AI-powered diagnostic mobile cancer and diabetes screening technology Ophtascan™ gains distribution in Sri Lanka
The technology can also be used for detecting type 2 diabetes.
- The technology can also be used for detecting type 2 diabetes.
- The mobile screening technology is used by doctors and patients in Central Africa, where there is huge demand for diabetes and cancer screening plus diagnostics.
- The Oncotech AI diagnostic and machine learning system then sends the results back to the clinician in under a minute.
- Oncotech Nordic AB CEO Andre Rafnsson concluded, "Sri Lanka is the third of what will be several new telemedicine and remote health diagnostic business partners.